Navigation Links
Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
Date:6/25/2012

PARSIPPANY, N.J. and BETHLEHEM, Pa., June 25, 2012 /PRNewswire/ -- Today, Daiichi Sankyo, Inc. received U.S. Food and Drug Administration (FDA) approval to package product at its first United States-based packaging facility located in Bethlehem, PA. With this approval, the Company expands its global supply chain capability, helping to ensure the supply of medicine to U.S. physicians and their patients.

At this time, the 140,000 square foot facility will package some of the Company's portfolio of marketed products for cardiovascular and metabolic therapies including treatments for hypertension and heart disease, diabetes and hyperlipidemia. Looking ahead, the facility could assume additional responsibilities related to clinical trial materials and perform formulation and analytical testing for select products.

"From facility and process design to quality control and personnel flow, we incorporated leading-edge technology in the design and development of the Bethlehem facility," said Jeff Lane, Vice President, Operations, Daiichi Sankyo, Inc. "The commissioning of this facility is a major milestone for our U.S. organization and augments our ability to manufacture and distribute quality medicines."

The plant currently employs approximately 39 full-time employees and will continue to add employees until realizing its full operational goals. Responsibilities range from Line Operators and Material Handlers to Project Engineers and Quality Specialists. Daiichi Sankyo worked with a number of regional and local business leaders and organizations, including the Governor's Action Team, Lehigh Valley Economic Development Corporation, Northampton County and City of Bethlehem to make this milestone possible.

Lane added that by expanding the Company's business operations to include manufacturing in the U.S., the Company is helping to minimize risks associated with product supply, and is able to gain greater control over the life cycle of its products, from research and development through packaging and distribution.

About Daiichi Sankyo

The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit www.daiichisankyo.com. Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is a member of the Daiichi Sankyo Group.  For more information on Daiichi Sankyo, Inc., please visit www.dsi.com.


'/>"/>
SOURCE Daiichi Sankyo
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Biologic Receives SFDA Manufacturing Approval Certificate for Human Coagulation Factor VIII
2. Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
3. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
4. Tetra Discovery Partners Receives Major NIH Award To Develop New Alzheimers Drug
5. Celladon Corporation Receives Notice of Allowance from European Patent Office
6. GSK Receives FDA Approval for MenHibrix®
7. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
8. Cochlear Americas Receives FDA Approval of the Worlds Thinnest, Full Length Electrode for Cochlear Implantation
9. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
10. PharmaNet/i3 Receives Distinguished Partner Award from the US Chinese Anti-Cancer Association
11. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2020)... ... September 02, 2020 , ... ... Penetration Technology, LLC, (APT) a Texas- and Indiana-based company ( http://www.aptt3x.com ) ... Counter (OTC) products, was today provided results of an independent laboratory evaluation ...
(Date:9/1/2020)... ... September 01, 2020 , ... Agilent, a ... Agilent Science and Technology Virtual Symposium 2020 (ASTVS 2020) on September ... a suite of Live webinars and Networking sessions, with a vast array of ...
(Date:9/1/2020)... ... 2020 , ... Neil Oberfeld of global law firm Greenberg ... of Trustees and committee chair of the Governance Committee for Mile High United ... that fights for the education, health, and financial stability of residents across Adams, ...
Breaking Medicine Technology:
(Date:8/28/2020)... ... August 28, 2020 , ... ... to a customized Lighthouse Health & Wellness mobile app and web-portal. NCPCV received ... Motorola Solutions Foundation awards grants each year to organizations, such as Destination Imagination, ...
(Date:8/28/2020)... ... August 28, 2020 , ... Integrated Viral Protection (IVP ... Florida school to deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is ... Classical Academy plans to fully reopen equipped with the filtration system on September 8th. ...
(Date:8/28/2020)... ... August 28, 2020 , ... A ... suggest that obese individuals are at an increased risk of developing severe COVID-19 ... to catch COVID-19; however, because the same organ systems that the coronavirus attacks ...
(Date:8/27/2020)... ... August 27, 2020 , ... The ... a leading aesthetic and wellness retreat. The practice is centered on results and ... Las Vegas. , Designed to be a sanctuary for total body renewal ...
(Date:8/26/2020)... ... 2020 , ... Smile Brands Inc. CEO, Steven C. Bilt, ... a session entitled, “A CEO Guide for Delivering and Measuring Inclusion Success”. The ... together the world’s leading diversity and inclusion executives, HR consultants, and D&I activists ...
Breaking Medicine News(10 mins):